0 NASDAQ Companies - July 9, 2024Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical TrialBaptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical […]Read More
0 NASDAQ Companies - July 9, 2024Janover’s AI Loan Advisor Generated Over 4,000 Deals Worth Over $25B to Date in 2024Facilitated Nearly $10M in Funded Loans This Year Made more than 1,600 real time email introductions to internal sales representatives, […]Read More
0 NASDAQ Companies - July 9, 2024Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical […]Read More
0 NASDAQ Companies - July 9, 2024Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board— Dr. Laufer is an immunologist advancing the scientific understanding and treatment of autoimmune diseases — BERKELEY, Calif., July 09, […]Read More
0 NASDAQ Companies - July 9, 2024Clene Announces 1-for-20 Reverse Stock SplitSALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]Read More
0 NASDAQ Companies - July 9, 2024Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease– Abiprubart Phase 2b clinical trial in Sjögren’s Disease to evaluate treatment response across biweekly and monthly subcutaneous administrations – – […]Read More
0 NASDAQ Companies - July 9, 2024Amesite Reports 93% Accuracy of NurseMagic™ App in Answering NCLEX Model QuestionsDETROIT, July 09, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based […]Read More
0 NASDAQ Companies - July 9, 2024ORLADEYO® (berotralstat) Approved in PeruRESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate […]Read More
0 NASDAQ Companies - July 9, 202460 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior TreatmentWASHINGTON, July 09, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), […]Read More
0 NASDAQ Companies - July 9, 2024Sotherly Hotels Inc. Announces Refinancing and Relaunch Plans for Jacksonville, FL HotelWILLIAMSBURG, Va., July 09, 2024 (GLOBE NEWSWIRE) — Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) today announced that the Company […]Read More